Please assess the completion status of the following clinical trial:

Trial Title: The Protection Effect of Speeda® Rabies Vaccine for Human Use

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Parent/legal acceptable representatives of children or the adult participants are willing and able to understand the protocol requirements and provide informed consent signed~* Participant is considered to be in good health including the body and mental status on the basis of reported medical history and limited physical examination and live in local ≥ 12 months before injured~* The man-killer could found and detect whether it carries the virus~Exclusion Criteria:~* Known bleeding disorder or suspected impairment of immunologic function, or receipt of immunosuppressive therapy or immunoglobulin since birth~* Apply passive immunity preparation

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- rabies vaccine (Type: EXPERIMENTAL): When injured by the animal who carries the rabies virus, the patient after standard treatment would survive or die

Based on this trial design, predict the completion outcome and termination type (if applicable).